Launch Excellence: Wins, Wobbles & Lessons Learned

Tom Caravela sits down with Ramin Farhood to discuss the intricacies of product launches within the pharmaceutical industry. They explore indicators of a successful launch and lessons learned from past challenges. The conversation delves into market access, reimbursement, and the critical impact of team alignment. Ramin highlights the balance between speed and safety, the importance of compliance, and the dangers of siloed operations. They also consider the role of digital and AI, patient insights, and provide practical advice for companies preparing for their first launch.

In this episode of MSL Talk, host Tom Caravela sits down with India Scales, Medical Science Liaison at AstraZeneca, for a powerful and refreshingly honest conversation about authenticity in the MSL role. India shares her inspiring journey from clinical pharmacist to MSL — including the setbacks, self-reflection, and growth that shaped her success. From navigating her first sign-off presentation to mastering the art of storytelling, she opens up about how vulnerability, self-awareness, and emotional intelligence have fueled her professional development. Together, Tom and India explore what it truly means to “be your human self” in Medical Affairs — balancing authenticity with professionalism, building trust and credibility, and finding your unique voice in a regulated environment. Whether you’re a new MSL finding your footing or a seasoned professional looking to reconnect with purpose, this episode offers invaluable insight into why authenticity isn’t just a trait — it’s a superpower.

In this episode, Tom Caravela is joined by Kirk Shepherd to explore the importance of patient voices in clinical decision-making, addressing access, equity, and diversity in oncology. They discuss balancing corporate pressures with a sense of purpose, and how patient feedback can shape clinical outcomes. The episode examines the evolving role of patients in clinical research and anticipated changes in oncology innovation, including technological advancements affecting participation. Ethical progress in the field is emphasized, concluding with thoughts on legacy in medical affairs and closing remarks.

In this episode, Tom Caravela welcomes Maria Urso for her third appearance, focusing on the art of scientific storytelling. Maria shares insights from her amazing medical affairs career and emphasizes the importance of engaging audiences through storytelling. She recounts her journey in mastering this skill, offering tips on crafting compelling scientific narratives. Maria illustrates storytelling in action with a memorable party story and an MSL example on the mechanism of action. Tom shares a personal story on confidence, and they discuss common storytelling mistakes, compliance, and building trust. The episode concludes with thoughts on the future of medical affairs and MSLs, along with closing remarks and gratitude.

In this episode, Tom Caravela explores the role of AI in the job search process and key factors that could lead to critical mistakes. The discussion begins with an overview of how AI can aid in resume optimization and the potential consequences of relying on these tools. Tom addresses the issue of age discrimination in resumes, offering insights into how AI can help mitigate this challenge. The episode also covers AI tools for interview preparation, highlighting common pitfalls to avoid. The conversation extends to AI's influence on compensation and offer negotiation, emphasizing the importance of using these tools responsibly. The episode wraps up with closing remarks and a call to action for listeners.

In this episode, Tom Caravela is joined by Nandini Sabharwal and Vivek Mukhatyar to explore the evolving role of AI tools in the Medical Science Liaison (MSL) field. Vivek shares his background and current role at Pfizer, while the conversation recaps the first part of this series. They discuss the limitations and evolution of AI, focusing on skill-building and collaboration. The episode highlights AI use cases, including business war games and personalized healthcare provider engagements, and explains agent mode in AI tools. The discussion anticipates future AI trends in Medical Affairs and AI's impact on healthcare provider and patient interactions. The episode concludes with favorite AI tools, an upcoming conference announcement, and closing remarks.

In this episode, Tom Caravela is joined by George Limen to discuss identifying and addressing rate limiting steps in the MSL field. They define rate limiting steps and their importance, offering insights into common mistakes by aspiring MSLs and self-diagnosis techniques. The conversation delves into interview performance evaluation, storytelling, and articulating a value proposition. Emphasizing continuous self-examination and competition awareness, they explore strategies for MSL career advancement, including resume tips and overcoming experienced MSL challenges. The episode concludes with advice on leveraging resources, evaluating progress, and continuous improvement, ending with a motivational note.

In this episode, Tom Caravela welcomes Maria Abunto to discuss the impact of competitive intelligence within medical affairs and its significance for Medical Science Liaisons (MSLs). They define the concept and discuss various methods and tools for intelligence gathering, emphasizing compliance and the role of competitive intelligence in decision-making and scientific discussions. Challenges in intelligence gathering and the importance of cross-functional collaboration are explored, alongside ethical considerations and potential collaborations with competitors. The conversation offers advice for new MSLs, discussing the role of AI and digital health, and encourages MSLs to adopt an analytical mindset.

In this episode, Tom Caravela and Daniel Snyder explore the rise of fractional medical affairs roles in the post-COVID era. They define interim and fractional positions, highlighting how they benefit both job seekers and companies. The discussion covers the increase in these roles, company utilization of interim talent, disadvantages, and compensation expectations, offering negotiation tips for candidates. They also discuss the future of fractional staffing, market trends, and the gig economy's impact on pharma and biotech. The episode ends with cost-effective strategies and gratitude to the audience.

In this episode, Tom Caravela is joined by Lusine Kodagolian to discuss how to measure the value of medical affairs. They explore the SMART framework, emphasizing its application in measuring scientific ROI and share of scientific voice. The discussion highlights the balance of various metrics and how to build a business case for SMART metrics, especially for smaller or early-stage companies. The conversation covers insights versus impact measurement and the implementation of new strategies. Consistency, trends, and feedback in metric analysis are underscored as essential elements. The episode concludes with actionable steps for integrating these strategies in medical affairs.